Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Capital Employed (2021 - 2025)

Goldenwell Biotech (GWLL) has disclosed Return on Capital Employed for 4 consecutive years, with 0.16% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.16%, compared with a TTM value of 0.16% through Sep 2025, changed N/A, and an annual FY2024 reading of 0.12%, changed N/A over the prior year.
  • Return on Capital Employed was 0.16% for Q3 2025 at Goldenwell Biotech, up from 0.09% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.16% in Q3 2025 and bottomed at 0.96% in Q2 2022.
  • Average Return on Capital Employed over 4 years is 0.32%, with a median of 0.26% recorded in 2021.
  • Peak annual rise in Return on Capital Employed hit -64bps in 2022, while the deepest fall reached -64bps in 2022.
  • Year by year, Return on Capital Employed stood at 0.37% in 2021, then tumbled by -84bps to 0.68% in 2022, then soared by 78bps to 0.15% in 2024, then skyrocketed by 206bps to 0.16% in 2025.
  • Business Quant data shows Return on Capital Employed for GWLL at 0.16% in Q3 2025, 0.09% in Q2 2025, and 0.15% in Q4 2024.